E

Euroapi SAS
PAR:EAPI

Watchlist Manager
Euroapi SAS
PAR:EAPI
Watchlist
Price: 3.112 EUR 0.39% Market Closed
Market Cap: 297.5m EUR

Wall Street
Price Targets

EAPI Price Targets Summary
Euroapi SAS

Wall Street analysts forecast EAPI stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EAPI is 2.861 EUR with a low forecast of 2.343 EUR and a high forecast of 3.675 EUR.

Lowest
Price Target
2.343 EUR
25% Downside
Average
Price Target
2.861 EUR
8% Downside
Highest
Price Target
3.675 EUR
18% Upside
Euroapi SAS Competitors:
Price Targets
AUROPHARMA
Aurobindo Pharma Ltd
14% Upside
600993
Mayinglong Pharmaceutical Group Co Ltd
32% Upside
603566
Pulike Biological Engineering Inc
36% Upside
SNT
Syntara Ltd
325% Upside
MANKIND
Mankind Pharma Ltd
28% Upside
HROW
Harrow Health Inc
61% Upside
XERS
Xeris Biopharma Holdings Inc
65% Upside
SNDL
Sundial Growers Inc
166% Upside

Revenue
Forecast

Revenue Estimate
Euroapi SAS

For the last 4 years the compound annual growth rate for Euroapi SAS's revenue is -1%. The projected CAGR for the next 4 years is 1%.

-1%
Past Growth
1%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Euroapi SAS

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-62%
Average Miss

Net Income
Forecast

Net Income Estimate
Euroapi SAS

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EAPI's stock price target?
Price Target
2.861 EUR

According to Wall Street analysts, the average 1-year price target for EAPI is 2.861 EUR with a low forecast of 2.343 EUR and a high forecast of 3.675 EUR.

What is Euroapi SAS's Revenue forecast?
Projected CAGR
1%

For the last 4 years the compound annual growth rate for Euroapi SAS's revenue is -1%. The projected CAGR for the next 4 years is 1%.

Back to Top